Treatment Overview
The Geographic Atrophy Monitoring Program is a specialized retinal care protocol for patients with advanced dry Age-Related Macular Degeneration (AMD). GA is characterized by the progressive degeneration of the retinal pigment epithelium (RPE) and photoreceptors, leading to gradual central vision loss. Monitoring programs aim to track disease progression, identify high-risk areas, and guide early interventions to slow vision deterioration.
In Korea, GA monitoring is performed using advanced multimodal imaging and AI-assisted analysis:
- Optical Coherence Tomography (OCT) and OCT-Angiography (OCT-A) for retinal layer assessment and microvascular evaluation
- Fundus Autofluorescence (FAF) to detect RPE loss and areas of atrophy
- High-resolution color fundus photography for documentation and longitudinal comparison
- AI-based imaging analytics to quantify atrophy size, growth rate, and progression risk
- Digital patient dashboards to track disease over time
- Integration with lifestyle, nutritional, and low-vision counseling
- Personalized follow-up schedules based on progression rate and risk factors
The program allows for proactive management of GA, early identification of vision-threatening changes, and personalized care planning.
Purpose & Benefits
Purpose
- Track GA progression and expansion over time
- Identify areas at highest risk for functional vision loss
- Guide lifestyle, nutritional, or preventive interventions
- Support timely referral for emerging therapies (e.g., complement inhibitors)
- Provide longitudinal documentation for ongoing retinal assessment
- Enable patient-specific follow-up intervals based on disease trajectory
Benefits
- Non-invasive, safe, and painless monitoring
- Early detection of vision-threatening changes
- AI-assisted quantification ensures objective and reproducible results
- Supports personalized preventive strategies and care plans
- Minimizes unnecessary clinic visits with risk-based scheduling
- Integrates multiple imaging modalities for comprehensive assessment
- Digital records allow longitudinal comparison and early intervention planning
Ideal Candidates
The Geographic Atrophy Monitoring Program in Korea is ideal for:
- Patients with advanced dry AMD or diagnosed GA
- Individuals with drusen and pigmentary changes at high risk for GA
- Patients seeking structured follow-up and progression tracking
- Those participating in clinical trials or emerging GA therapies
- Individuals requiring comprehensive imaging and personalized care planning
Possible Risks & Complications
Minor / Transient Issues
- Mild light sensitivity during imaging
- Temporary eye fatigue from prolonged fixation
- Slight discomfort if pupil dilation is used
Rare / Serious Risks
- Minimal risk since all imaging modalities are non-invasive
- Rare allergic reaction to pupil-dilating drops (if used)
How Korean Clinics Minimize Risks
- Use of non-invasive imaging techniques for safe monitoring
- AI-assisted imaging reduces need for repeated or excessive imaging
- Experienced retinal specialists and technicians oversee procedures
- Optional pupil dilation only when necessary for high-quality imaging
Related Diagnostic & Treatment Techniques
- Optical Coherence Tomography (OCT) – Evaluate retinal layers and atrophy
- OCT-Angiography (OCT-A) – Detect microvascular changes near GA
- Fundus Autofluorescence (FAF) – Track RPE loss and atrophic regions
- Color Fundus Photography – Baseline and longitudinal documentation
- Low-Vision Rehabilitation – Support for patients with functional vision loss
- Lifestyle & Nutritional Counseling – Optimize visual function and reduce progression risk
- Emerging GA Therapies (Complement Inhibitors) – Integrated into monitoring programs
Treatment Process in Korea
Step 1 – Initial Assessment
- Comprehensive eye exam including visual acuity and intraocular pressure
- Multimodal imaging: OCT, OCT-A, FAF, and fundus photography
- AI-assisted analysis of GA area, progression rate, and risk factors
- Personalized care plan with follow-up intervals
Step 2 – Ongoing Monitoring
- Scheduled imaging sessions every 3–12 months based on progression risk
- AI-assisted quantification of atrophy growth and functional impact
- Integration of imaging data with patient digital dashboard
- Adjustments to lifestyle, nutritional, or therapeutic interventions as needed
Step 3 – Intervention Planning
- Early referral to emerging therapies if rapid GA progression detected
- Coordination with low-vision rehabilitation specialists
- Regular counseling on preventive measures and vision support
Duration: 30–60 minutes per visit
Setting: Outpatient retina clinic with multimodal imaging
Recovery & After-Care
After-Care Guidelines
- No recovery period required; non-invasive imaging
- Avoid rubbing eyes if dilation drops were used
- Maintain scheduled follow-up appointments for longitudinal tracking
- Report any sudden changes in vision promptly
Recovery Timeline
- Immediate: Imaging completed with no long-term effects
- 24 Hours: Effects of dilation (if used) resolve
- Ongoing: Structured follow-up according to disease progression
Results & Longevity
Expected Results
- Precise quantification of GA area and progression rate
- Identification of high-risk zones for potential vision loss
- Early detection of changes guiding timely intervention
- Comprehensive longitudinal data to guide long-term care
- Integration with low-vision and preventive strategies
Longevity
- Safe for repeated use over years for ongoing monitoring
- Digital records allow comparison across multiple time points
- Supports long-term management of GA and advanced dry AMD
Why Korea Is a Top Destination
- Highly experienced retina specialists in AMD and GA management
- Advanced multimodal imaging systems with AI-assisted analysis
- Personalized GA monitoring programs with risk-based follow-up
- Integration with preventive care, nutritional counseling, and low-vision rehabilitation
- English-friendly clinics with structured long-term patient care
- Non-invasive and patient-friendly outpatient procedures
Unique Korean Innovations
- AI-assisted GA growth quantification and risk prediction
- Digital dashboards for longitudinal disease tracking
- Integration of multimodal imaging for comprehensive GA assessment
- Personalized follow-up intervals based on disease progression
- Early intervention planning for emerging GA therapies
- Lifestyle and nutrition counseling integrated with clinical data
Cost Range (Indicative Estimate)
| Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Initial GA Assessment | ₩500,000 – ₩900,000 | ~$380 – $700 | Multimodal imaging + AI analysis + consultation |
| Ongoing Monitoring Visit | ₩250,000 – ₩600,000 | ~$190 – $455 | FAF + OCT + OCT-A + digital tracking |
| Annual GA Monitoring Package | ₩1,000,000 – ₩2,500,000 | ~$765 – $1,900 | 3–5 visits + AI analysis + low-vision counseling |
Popular Clinics in Korea
- Kim’s Eye Hospital Retina Center (Seoul)
- Gangnam Severance Hospital Retina Clinic
- Seoul National University Hospital Ophthalmology Center
- B&VIIT Eye Center (Gangnam)
- BGN Eye Clinic (Seoul & Busan)
- NUNE Eye Hospital (Daegu)
- Glory Seoul Eye Clinic
- Dream Eye Center (Seoul)
